⌘K

Login Start Free

Home/Filings/4/0001209191-22-028725

4//SEC Filing

Vig Pamela 4

Accession 0001209191-22-028725

CIK 0001759425other

View on SEC.gov Company Profile

Filed

May 11, 8:00 PM ET

Accepted

May 12, 9:21 PM ET

Size

5.5 KB

Accession

0001209191-22-028725

Insider Transaction Report

Form 4

Period: 2022-05-10

Mirum Pharmaceuticals, Inc.MIRM

Chief Scientific Officer

Transactions

Award
Common Stock
2022-05-10$13.57/sh+807$10,948→ 21,242 total

Holdings

Common Stock
(indirect: By Trust)
75,000

Footnotes (1)

[F1]This Form 4 is being filed voluntarily to report the acquisition of 807 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780069

Filing Metadata

Form type: 4
Filed: May 11, 8:00 PM ET
Accepted: May 12, 9:21 PM ET
Size: 5.5 KB

View on SEC.gov